Focus
With a focus in specialized diagnostic devices, Konan’s flagship specular microscopes are recognized eye care practitioners, regulatory groups, professional reading centers, and clinical trial experts as the gold standard for endothelial cell density analysis. Additional diagnostics are expanding Konan’s specialty into color vision deficiencies (also described questionably as color blindness), high definition pupillography, and visual acuity + ocular performance.
Brands
Konan Medical owns or represents well recognized ophthalmic brands including:
CellChek™ | Center Method™ | RAPDx® | ColorDx® | Chart2020® | EvokeDx® | icVEP™
EyeKinetix™ will have visibility in 2016.
Market Position
Konan Medical USA, Inc. has a global sales and distribution channel comprised of direct sales, selected sales representatives, and distributors with extensive eye care experience. Today there are over 20,000 Konan systems and products in use in 60 countries worldwide and all 50 states in the USA using Konan specialized diagnostic products. Konan’s clinical trials services program counts virtually every FDA registered manufacturer of ophthalmic implantable and pharmaceuticals as customers. Konan continues to earn its predominant position in the marketplace with core strengths in clinical evidence, web-enabled customer support, expert service, and leading technologies. Konan additionally is the market leader in the donor cornea tissue / eye bank specular microscopy segment.
Business Development & Investment
Konan Medical USA, Inc. actively seeks promising new technologies & products to complement its existing product line and leverage the capabilities of its extensive distribution network. To explore opportunities for cooperation, please contact Charles Wm. Stewart, OD, or Dale Sadlik.
